Synapse - Mark Weiss

Results (86)

The Warburg effect confers adverse outcome in chronic lymphocytic leukemia

Meeting Abstract

Gardner, J. R.; Devlin, S. M.; Knapp, K.; Bauli, F.; Patel, M.; Lamanna, N.; Frattini, M. G.; Brentjens, R.; Maslak, P.; Jurcic, J. G.; more...
Clinical Lymphoma, Myeloma and Leukemia (2014)

Fulltext@MSK | Save

Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia

Journal Article

Maslak, P. G.; Dao, T.; Krug, L. M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Zhang, R.; Wolchok, J. D.; Yuan, J.; Pinilla-Ibarz, J.; more...
Blood (2010)

Fulltext@MSK | Save

Chronic lymphocytic leukemia

Book Section

Wierda, W. G.; Lamanna, N.; Weiss, M. A.
In Pazdur, R.; Wagman, L. D.; Camphausen, K. A.; Hoskins, W. J. (Eds.) Cancer Management: A Multidisciplinary Approach. 12th ed (2009)

Fulltext@MSK | Save

Enhanced in vivo activation of adoptively transferred genetically targeted T cells following cyclophosphamide chemotherapy: Initial results from a phase I clinical trial treating CLL patients with autologous CD19-targeted T cells

Meeting Abstract

Brentjens, R. J.; Hollyman, D.; Park, J.; Santos, E.; Yeh, R.; Stefanski, J.; Taylor, C.; Weiss, M. A.; Filippa, D.; Riviere, I.; more...
Blood (2009)

Fulltext@MSK | Save

Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia

Journal Article

Lamanna, N.; Weiss, M. A.
Current Hematologic Malignancy Reports (2009)

Fulltext@MSK | Save

Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses

Journal Article

Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A phase I trial for the treatment of purine analog-refractory chronic lymphocytic leukemia using autologous T cells genetically targeted to the B cell specific antigen CD19

Meeting Abstract

Brentjens, R. J.; Hollyman, D.; Weiss, M.; Stefanski, J.; Przybylowski, M.; Bartido, S.; Borquez-Ojeda, O.; Taylor, C.; Heaney, M.; Riviere, I.; more...
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Sequential cytarabine and alpha-particle immunotherapy with bismuth-213 ((213)Bi)-labeled-HuM195 (lintuzumab) for acute myeloid leukemia (AML)

Meeting Abstract

Rosenblat, T.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Weiss, M. A.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Larson, S. M.; Scheinberg, D. A.; more...
Blood (2008)

Fulltext@MSK | Save

Pentostatin in chronic lymphocytic leukemia

Journal Article

Sauter, C.; Lamanna, N.; Weiss, M. A.
Expert Opinion on Drug Metabolism and Toxicology (2008)

Fulltext@MSK | Save

Life-threatening serotonin toxicity due to a citalopram-fluconazole drug interaction: case reports and discussion

Journal Article

Levin, T. T.; Cortes-Ladino, A.; Weiss, M.; Palomba, M. L.
General Hospital Psychiatry (2008)

Fulltext@MSK | Save